GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurogene Inc (NAS:NGNE) » Definitions » Current Deferred Taxes Liabilities

Neurogene (Neurogene) Current Deferred Taxes Liabilities : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Neurogene Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Neurogene's current deferred tax liabilities for the quarter that ended in Mar. 2024 was $0.00 Mil.

Neurogene Current Deferred Taxes Liabilities Historical Data

The historical data trend for Neurogene's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurogene Current Deferred Taxes Liabilities Chart

Neurogene Annual Data
Trend Dec21 Dec22 Dec23
Current Deferred Taxes Liabilities
- - -

Neurogene Quarterly Data
Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Deferred Taxes Liabilities Get a 7-Day Free Trial - - - - -

Neurogene Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Neurogene's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurogene (Neurogene) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
535 W 24th Street, 5th Floor, New York, NY, USA, 10011
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Neurogene (Neurogene) Headlines